Publication | Closed Access

Phase I/II Trial of Custirsen (OGX-011), an Inhibitor of Clusterin, in Combination with a Gemcitabine and Platinum Regimen in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer

OncologyMedicineBronchial NeoplasmPlatinum RegimenPhase I/ii TrialCancer TreatmentPharmacologyRadiation OncologyLung Cancer